Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-24-126354
Filing Date
2024-12-06
Accepted
2024-12-06 17:05:10
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1 tm2430338-1_s1.htm S-1 544651
2 EXHIBIT 5.1 tm2430338d2_ex5-1.htm EX-5.1 9495
3 EXHIBIT 23.1 tm2430338d2_ex23-1.htm EX-23.1 2347
4 EX-FILING FEES tm2430338d2_ex-filingfees.htm EX-FILING FEES 23016
5 GRAPHIC tm2430338d2_ex5-1img001.jpg GRAPHIC 2943
6 GRAPHIC lg_transcodetheratm-4c.jpg GRAPHIC 19810
7 GRAPHIC fc_modular-4c.jpg GRAPHIC 82035
8 GRAPHIC tb_pipeline-4c.jpg GRAPHIC 47024
  Complete submission text file 0001104659-24-126354.txt   787978
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-283668 | Film No.: 241533095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)